Barry R Imhoff
Overview
Explore the profile of Barry R Imhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vazquez Cegla A, Hedden C, Imhoff B, Cui G, McCarty N
Heliyon
. 2024 Oct;
10(18):e37977.
PMID: 39381220
The study of many diseases is limited by the systems available. Cystic Fibrosis-Related Diabetes (CFRD), the main co-morbidity of Cystic Fibrosis (CF), is a perfect example. Cells experience glucose fluctuations...
2.
Taylor W, Imhoff B, Sathi Z, Liu W, Garza K, Dias B
Learn Mem
. 2021 Mar;
28(4):126-133.
PMID: 33723032
Dysfunctions in memory recall lead to pathological fear; a hallmark of trauma-related disorders, like posttraumatic stress disorder (PTSD). Both, heightened recall of an association between a cue and trauma, as...
3.
Cui G, Stauffer B, Imhoff B, Rab A, Hong J, Sorscher E, et al.
Sci Rep
. 2019 Sep;
9(1):13460.
PMID: 31530897
VX-770 (ivacaftor) is approved for clinical use in CF patients bearing multiple CFTR mutations. VX-770 potentiated wildtype CFTR and several disease mutants expressed in oocytes in a manner modulated by...
4.
Agarwal R, Johnson C, Imhoff B, Donlan R, McCarty N, Garcia A
Nat Biomed Eng
. 2019 Mar;
2(11):841-849.
PMID: 30854250
No abstract available.
5.
Molina S, Moriarty H, Infield D, Imhoff B, Vance R, Kim A, et al.
Am J Physiol Lung Cell Mol Physiol
. 2017 Feb;
312(5):L688-L702.
PMID: 28213469
Cystic fibrosis-related diabetes is the most common comorbidity associated with cystic fibrosis (CF) and correlates with increased rates of lung function decline. Because glucose is a nutrient present in the...
6.
Cui G, Khazanov N, Stauffer B, Infield D, Imhoff B, Senderowitz H, et al.
Am J Physiol Lung Cell Mol Physiol
. 2016 Jun;
311(2):L192-207.
PMID: 27288484
VX-770 (Ivacaftor) has been approved for clinical usage in cystic fibrosis patients with several CFTR mutations. Yet the binding site(s) on CFTR for this compound and other small molecule potentiators...
7.
Timme-Laragy A, Goldstone J, Imhoff B, Stegeman J, Hahn M, Hansen J
Free Radic Biol Med
. 2013 Jun;
65:89-101.
PMID: 23770340
Embryonic development involves dramatic changes in cell proliferation and differentiation that must be highly coordinated and tightly regulated. Cellular redox balance is critical for cell fate decisions, but it is...
8.
Imhoff B, Hansen J
Cell Mol Biol Lett
. 2011 Jan;
16(1):149-61.
PMID: 21225471
Development is an orderly process that requires the timely activation and/or deactivation of specific regulatory elements that control cellular proliferation, differentiation and apoptosis. While many studies have defined factors that...
9.
Imhoff B, Hansen J
Differentiation
. 2010 May;
80(1):31-9.
PMID: 20471742
Oxidized extracellular redox states have been associated with many diseases related to obesity, including heart disease and diabetes, but relatively little is known about the relationship between extracellular redox states...
10.
Imhoff B, Hansen J
Cell Biol Toxicol
. 2010 Apr;
26(6):541-51.
PMID: 20429028
Tert-butylhydroquinone (tBHQ), the major metabolite of butylated hydroxyanisole, induces an antioxidant response through the redox-sensitive transcription factor, nuclear factor-E2-related factor-2 (Nrf2). However, the mechanism by which tBHQ induces Nrf2 activity...